Skip to main content
Log in

Long-term follow-up of children with craniopharyngioma

  • Original Investigations
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Management of craniopharyngiomas is still controversial. 28 children with this tumor were studied. GH deficiency was present in 22 patients following surgery, 10 of these GH-lacking patients had normal or accelerated growth (usually associated with rapid weight gain) postoperatively. Somatomedin levels were normal in three of six normally growing patients. After craniotomy their basal and TRH-stimulated prolactin levels were in the normal range, but their insulin secretion was markedly increased. Postoperatively there was a significant correlation between peak insulin levels following arginine infusion and growth velocity in all patients.

Complete tumor removal could be performed in 28% of our patients. Altogether 36% of all patients had at least one tumor recurrence. Recent literature with the addition of our series showed tumor recurrence in 22% of patients with “total” tumor excision and in 72% of patients with partial tumor removal. Radiotherapy seems to be capable of destroying craniopharyngioma tissue. The recurrence rate was only 26% in patients with subtotal excision plus radiotherapy. Unless radical tumor removal can be attempted with safety, subtotal tumor removal plus radiotherapy appears to be the treatment of choice for craniopharyngioma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

SD:

Standard Deviation

SDS:

Standard Deviation Score

SEM:

Standard Error of the Mean

BA:

Bone Age

CA:

chronological Age

RIA:

Radioimmunoassay

GH:

Growth Hormone

TRH:

Thyrotropin Releasing Hormone

References

  1. Ahlskog JE, Hoebel BG (1973) Overeating and obesity from damage to a noradrenergic system in the brain. Science 182: 166–169

    Google Scholar 

  2. Amacher AL (1980) Craniopharyngioma: The controversy regarding radiotherapy. Child's brain 6:57–64

    Google Scholar 

  3. Azar-Kia B, Krishnan UR, Schechter MM (1975) Neonatal craniopharyngioma. J Neurosurg 42:91–93

    Google Scholar 

  4. Bamford FN, Jones PM, Pearson D, Ribeiro GG, Shalet SM, Beardwell CG (1976) Residual disabilities in children treated for intracranial space-occupying lesions. Cancer 37:1149–1151

    Google Scholar 

  5. Banna M (1976) Craniopharyngioma: Based on 160 cases. Br J Radiol 49:206–223

    Google Scholar 

  6. Banna M, Hoare RD, Stanley P, Till K (1973) Craniopharyngioma in children. J Pediatr 83:781–785

    Google Scholar 

  7. Bartlett JR (1971) Craniopharyngiomas—a summary of 85 cases. J Neurol Neurosurg Psychiatry 34:37–41

    Google Scholar 

  8. Beck JC, Gonda A, Hamid MA, Morgen RO, Rubinstein D, McGarry EE (1964) Some metabolic changes induced by primate growth hormone and purified ovine prolactin. Metabolism 13:1108–1134

    Google Scholar 

  9. Bloom HJG (1975) Combined modality therapy for intracranial tumors. Cancer 35:111–120

    Google Scholar 

  10. Bray GA (1979) Nutritional factors in disease. In: Sodeman WA, Sodeman TM (eds) Pathologic Physiology. WB Saunders, London Philadelphia Toronto, pp 971–976

    Google Scholar 

  11. Carpenter RC, Chamberlin GW, Frazier CH (1937) The treatment of hypophyseal stalk tumors by evacuation and irradiation. Am J Roentgenol 38:162–177

    Google Scholar 

  12. Costin G, Kogut MD, Phillipps LS, Daughaday WH (1976) Craniopharyngioma: The role of insulin in promoting postoperative growth. J Clin Endocrinol Metab 42:370–379

    Google Scholar 

  13. Daughaday WH, Phillipps LS, Mueller MC (1976) The effects of insulin and growth hormone on the release of somatomedin by the isolated rat liver. Endocrinology 98:1214–1219

    Google Scholar 

  14. Eiser C (1978) Intellectual abilities among survivors of childhood leukaemia as a function of CNS irradiation. Arch Dis Child 53:391–395

    Google Scholar 

  15. Finkelstein JW, Kream J, Ludan A, Hellman L (1972) Sulfation factor (somatomedin): An explanation for continued growth in the absence of immunoassayable growth hormone in patients with hypothalamic tumors. J Clin Endocrinol Metab 35:13–17

    Google Scholar 

  16. Francis MJO, Hill DJ (1975) Prolactin-stimulated production of somatomedin by rat liver. Nature 255:167–168

    Google Scholar 

  17. Frasier SD, Smith FG (1968) Return of normal growth following removal of a craniopharyngioma. Am J Dis Child 116:311–314

    Google Scholar 

  18. Frohman LA, Bernardis LL (1968) Growth hormone and insulin levels in weanling rats with ventromedial hypothalamic lesions. Endocrinology 82:1125–1132

    Google Scholar 

  19. Girard J (1981) Intracranial space-occupying lesions. In: Brook CGD (ed) Clinical Paediatric Endocrinology. Blackwell Scientific, Oxford London, pp 275–284

    Google Scholar 

  20. Gluckman PD, Holdaway IM (1976) Prolactin and somatomedin studies in the syndrome of growth hormone-independent growth. Clin Endocrinol 5:545–549

    Google Scholar 

  21. Greulich WW, Pyle SI (1959) Radiographic atlas of skeletal development of the hand and wrist, 2nd ed. Oxford University, London

    Google Scholar 

  22. Harris JR, Levene MB (1976) Visual complications following irradiation for pituitary adenomas and craniopharyngiomas. Radiology 120:167–171

    Google Scholar 

  23. Hill DJ, Francis MJO, Milner RDG (1977) Action of rat prolactin on plasma somatomedin levels in the rat and on somatomedin release from perfused rat liver. J Endocrinol 75:137–143

    Google Scholar 

  24. Hoff JT, Patterson RH (1972) Craniopharyngiomas in children and adults. J Neurosurg 36:299–302

    Google Scholar 

  25. Hoffman HJ, Hendrick EB, Humphreys RP, Buncic JR, Armstrong DL, Jenkin RDT (1977) Management of craniopharyngioma in children. J Neurosurg 47:218–227

    Google Scholar 

  26. Holder AT, Preece MA (1981) The somatomedins. In: Brook CGD (ed) Clinical Paediatric Endocrinology. Blackwell Scientific, Oxford London, pp 96–112

    Google Scholar 

  27. Holder AT, Wallis M, Biggs P, Preece MA (1980) Effects of growth hormone, prolactin and thyroxine on body weight, somatomedin-like activity and in-vivo sulphation of cartilage in hypopituitary dwarf mice. J Endocrinol 85:35–47

    Google Scholar 

  28. Holmes LB, Frantz AG, Rabkin MT, Soeldner JS, Crawford JD (1968) Normal growth with subnormal growth hormone levels. N Engl J Med 279:559–566

    Google Scholar 

  29. Inoue S, Bray GA, Mullen YS (1978) Transplantation of pancreatic β-cells prevents development of hypothalamic obesity in rat. Am J Physiol 235:E 266-E 271

    Google Scholar 

  30. Iyer CGS (1952) Case report of an adamantinoma present at birth. J Neurosurg 9:221–228

    Google Scholar 

  31. Jenkins JS, Gilbert CJ, Ang V (1976) Hypothalamic-pituitary function in patients with craniopharyngiomas. J Clin Endocrinol Metab 43:394–399

    Google Scholar 

  32. Kahn EA, Gosch HH, Seeger JF, Hicks SP (1973) Forty-five years experience with the craniopharyngiomas. Surg Neurol 1:5–12

    Google Scholar 

  33. Katz EL (1975) Late results of radical excision of craniopharyngiomas in children. J Neurosurg 42:86–90

    Google Scholar 

  34. Kennedy HB, Smith RJS (1975) Eye signs in craniopharyngioma. Br J Ophthalmol 59:689–695

    Google Scholar 

  35. Kenny FM, Guyda HJ, Wright JC, Friesen HG (1973) Prolactin and somatomedin in hypopituitary patients with “Catch-up” growth following operations for craniopharyngioma. J Clin Endocrinol Metab 36:378–380

    Google Scholar 

  36. Kramer S, Southard M, Mansfield CM (1968) Radiotherapy in the management of craniopharyngiomas. Am J Roentgenol 103:44–52

    Google Scholar 

  37. Leddy ET, Marshall TM (1951) Roentgen therapy of pituitary adamantinomas (craniopharyngiomas). Radiology 56:384–393

    Google Scholar 

  38. Lichter AS, Wara WM, Sheline GE, Townsend JJ, Wilson CB (1977) The treatment of craniopharyngiomas. Int J Radiat Oncol Biol Phys 2:675–683

    Google Scholar 

  39. Martin JM, Konijnendijk W, Bouman PR (1974) Insulin and growth hormone secretion in rats with ventromedial hypothalamic lesions maintained on restricted food intake. Diabetes 23:203–208

    Google Scholar 

  40. Martins AN, Johnston JS, Henry JM, Stoffel TJ, DiChiro G (1977) Delayed radiation necrosis of the brain. J Neurosurg 47:336–345

    Google Scholar 

  41. Matson DD (1964) Craniopharyngioma. Clin Neurosurg 10: 116–129

    Google Scholar 

  42. Matson DD, Crigler JF (1969) Management of craniopharyngioma in childhood. J Neurosurg 30:377–390

    Google Scholar 

  43. McKissock W, Ford RK (1966) Results of treatment of the craniopharyngiomas. J Neurol Neurosurg Psychiatry 29:475

    Google Scholar 

  44. McMurry FG, Hardy RW, Dohn DF, Sadar E, Gardner WJ (1977) Long term results in the management of craniopharyngiomas. Neurosurgery 1:238–241

    Google Scholar 

  45. Mori K, Takeuchi J, Ishikawa M, Handa H, Toyama M, Yamaki T (1978) Occlusive arteriopathy and brain tumor. J Neurosurg 49:22–35

    Google Scholar 

  46. Mori K, Handa H, Murata T, Takeuchi J, Miwa S, Osaka K (1980) Results of treatment for craniopharyngioma. Child's brain 6: 303–312

    Google Scholar 

  47. Onoyama J, Ono K, Yabumoto E, Takeuchi J (1977) Radiation therapy of craniopharyngioma. Radiology 125:799–803

    Google Scholar 

  48. Petito CK, DeGirolami U, Earle KM (1976) Craniopharyngiomas. Cancer 37:1944–1952

    Google Scholar 

  49. Phillips LS (1979) Nutritional regulation of somatomedin activity and growth. In: Giordano G, van Wyk JJ, Minuto F (eds) Somatomedins and growth. Academic Press, London NewNork, pp 311–323

    Google Scholar 

  50. Shapiro K, Till K, Grant N (1979) Craniopharyngiomas in childhood. J Neurosurg 50:617–623

    Google Scholar 

  51. Sharma U, Tandon PN, Saxena KK, Singhal RM, Baruah JD (1974) Craniopharyngiomas treated by a combination of surgery and radiotherapy. Clin Radiol 25:13–17

    Google Scholar 

  52. Smith DK, Sarfeh J, Howard L (1983) Truncal vagotomy in hypothalamic obesity. Lancet 1:1330–1331

    Google Scholar 

  53. Sogg RL, Donaldson SS, Yorke CH (1978) Malignant astrocytoma following radiotherapy of a craniopharyngioma. J Neurosurg 48:622–627

    Google Scholar 

  54. Stahnke N, Schönberg D, Steins P, Willig RP, Blunck W (1975) Subnormal growth hormone (GH) levels with normal growth. Pediatr Res 9:674

    Google Scholar 

  55. Stahnke N, Blunck W (1979) Insulinsekretion bei 3 Gruppen von Patienten mit STH-Mangel. Klin Wochenschr 57:361

    Google Scholar 

  56. Stahnke N, Willig RP (1981) Endokrine Diagnostik von hypothalamisch-hypophysären Störungen im Kindesalter. Monatsschr Kinderheilkd 129:81–90

    Google Scholar 

  57. Stahnke N, Ilicki A, Willig RP (1979) Effects of cyproterone acetate (CA) on growth and endocrine function in precocious puberty. Acta Paediatr Scand [Suppl] 277:32–40

    Google Scholar 

  58. Svolos DG (1969) Craniopharyngiomas. Acta Chir Scand [Suppl] 403:1–44

    Google Scholar 

  59. Sweet WH (1976) Radical surgical treatment of craniopharyngioma. Clin Neurosurg 23:52–79

    Google Scholar 

  60. Tanner JM, Whitehouse RH, Takaishi M (1966) Standards from birth to maturity for height, weight, height velocity, and weight velocity: Britisch Children, 1965. Arch Dis Child 41:454–471; 613–635

    Google Scholar 

  61. Tanner JM, Whitehouse RH, Hughes PCR, Vince FP (1971) Effect of human growth hormone treatment for 1 to 7 years on growth of 100 children, with growth hormone deficiency, low birthweight inherited smallness. Turner's syndrome, and other complaints. Arch Dis Child 46:745–782

    Google Scholar 

  62. Thompson IL, Griffin TW, Parker RG, Blasko JC (1978) Craniopharyngioma: The role of radiation therapy. Int J Radiat Oncol Biol Phys 4:1059–1063

    Google Scholar 

  63. Thomsett MJ, Conte FA, Kaplan SL, Grumbach MM (1980) Endocrine and neurologic outcome in childhood craniopharyngioma: Review of effect of treatment in 42 patients. J Pediatr 97:728–735

    Google Scholar 

  64. Urdaneta N, Chessin H, Fischer JJ (1976) Pituitary adenomas and craniopharyngiomas: analysis of 99 cases treated with radiation therapy. Int J Radiat Oncol Biol Phys 1:895–902

    Google Scholar 

  65. Van den Brande JL, van Buul-Offers SC, DuCaju MVL, Price DA, Wit JM, Bongers-Schokking JJ (1979) Somatomedin and the regulation of statural growth. In: Giordano G, van Wyk JJ, Minuto F (eds) Somatomedins and growth. Academic Press, London New York, pp 255–261

    Google Scholar 

  66. Van der Schueren-Lodeweyckx M (1981) Endocrinology of growth. In: Brook CGD (ed) Clinical paediatric Endocrinology. Blackwell Scientific. Oxford London, pp 73–95

    Google Scholar 

  67. Van Wyk JJ, Underwood LE, Lister RC, Marshall RN (1973) The somatomedins. A new class of growth-regulating hormones? Am J Dis Child 126:705–711

    Google Scholar 

  68. Waga S, Handa H (1976) Radiation-induced meningioma: With review of literature. Surg Neurol 5:215–219

    Google Scholar 

  69. Weldon V (1972) In: Daughaday WH, Garland JT: The sulfation factor hypothesis: recent observations. In: Pecile A, Müller EE (eds) Growth and growth hormone. Excerpta Medica, International Congress Series No 244, Amsterdam

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stahnke, N., Grubel, G., Lagenstein, I. et al. Long-term follow-up of children with craniopharyngioma. Eur J Pediatr 142, 179–185 (1984). https://doi.org/10.1007/BF00442445

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00442445

Key words

Navigation